source
- Tempus acquires Personalis for $1.5 billion to expand cancer genomics and MRD testingTempus announced it will purchase Personalis in a transaction valued at $1.5 billion, giving it full ownership of the cancer‑genomics firm. The deal builds on a 2023 partnership where Tempus inves…
- Medicare proposes cuts to hospital payments for drugs and imaging under new outpatient ruleMedicare's Centers for Medicare & Medicaid Services released a proposed rule that would lower the amounts hospitals receive for certain prescription drugs and imaging services provided to Medicare…